Nuvation Bio (NUVB) Fundamental Analysis: Revenue, Earnings & Valuation

6.34 / 10

Outperform

NUVB demonstrates impressive year-over-year revenue growth of 873%, indicating robust top-line expansion. A high interest-coverage ratio of 15.65 suggests solid debt-service ability. However, an elevated days-sales-outstanding value of 135 signals potential inefficiencies in receivables collection. Inventory turnover is moderate at 2.81, and cost-of-sales remains contained at 38.1%. These metrics collectively point to a fundamentally sound yet not flawless business model that warrants monitoring for working-capital efficiency.

Analysis Checks(8/10)

Total operating revenue (YoY growth rate %)

Value873.03

Score2/3

Weight0.38%

1M Return0.16%

Days sales outstanding

Value135.05

Score0/3

Weight-4.86%

1M Return-2.35%

Inventory turnover ratio

Value2.81

Score3/3

Weight58.39%

1M Return25.25%

Accounts receivable turnover ratio

Value2.00

Score2/3

Weight-1.82%

1M Return-0.76%

PB-ROE

Value1.03

Score2/3

Weight29.29%

1M Return9.23%

Income tax / Total profit (%)

Value0.00

Score0/3

Weight-4.33%

1M Return-1.94%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.65

Score2/3

Weight-1.92%

1M Return-0.83%

Operating revenue (YoY growth rate %)

Value873.03

Score2/3

Weight0.61%

1M Return0.25%

Cost of sales ratio (%)

Value38.12

Score2/3

Weight0.83%

1M Return0.45%

Asset-MV

Value-0.49

Score2/3

Weight23.43%

1M Return7.15%

Is NUVB fundamentally strong?

NUVB scores 6.34/10 on fundamentals and holds a Discounted valuation at present. Backed by its -53.18% ROE, -325.31% net margin, -7.76 P/E ratio, 5.20 P/B ratio, and 71.56% earnings growth, these metrics solidify its Outperform investment rating.